Michael V. O’Shaughnessy

Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients

Hélène C. F. Côté, Zabrina L. Brumme, Kevin J.P. Craib et al. · New England Journal of Medicine · 2002 · 572 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +12

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

Robert S. Hogg, Katherine Heath, David R. Bangsberg et al. · AIDS · 2002 · 427 citations

Public Health, Pharmacology, Pharmacotherapy +17

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

Mark Tyndall, Sue Currie, Patricia M. Spittal et al. · AIDS · 2003 · 377 citations

Public Health, Infectious Disease Control, Behavioral Epidemiology +13

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 10⁹ cells/L

Evan Wood, Robert S. Hogg, Benita Yip et al. · Annals of Internal Medicine · 2003 · 363 citations

Public Health, Pharmacotherapy, Health Services Research +15

Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

Robert S. Hogg, Benita Yip, Charlotte Kully et al. · PubMed · 1999 · 324 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17